Fitness & Nutrition

Precision BioSciences Presents Preclinical Data Highlighting PBGENE-PMM as a Potential Therapy for Primary Mitochondrial Myopathy

Retrieved on: 
Tuesday, March 19, 2024
FDA, Other Health, Technology, Nanotechnology, Stem Cells, Pharmaceutical, Infectious Diseases, Genetics, Fitness & Nutrition, Clinical Trials, Science, Biotechnology, Other Science, Health, Research, Precision BioSciences, Conference, Gene editing, Cell, CTA, Mitochondrial myopathy, Mitochondrion, DNA, Smith, Doctor of Philosophy, IND, CRISPR, Heteroplasmy, PMM, Vaccine

These data are being presented at the Mitochondrial Medicine – Therapeutic Development Annual Conference, being held from March 18-20, 2024 in Hinxton, UK.

Key Points: 
  • These data are being presented at the Mitochondrial Medicine – Therapeutic Development Annual Conference, being held from March 18-20, 2024 in Hinxton, UK.
  • “Today’s data from our PBGENE-PMM program further validate our work with ARCUS and continue to demonstrate its ability to make precise edits while avoiding off-target activity,” said Jeff Smith, PhD, Chief Research Officer of Precision BioSciences.
  • PBGENE-PMM is designed to eliminate mutant mitochondrial DNA leaving normal functioning wild-type mitochondrial DNA intact to repopulate the cell, resulting in a shift in heteroplasmy and improvement in mitochondrial function.”
    Smith continued, “Additionally, ARCUS can cross mitochondrial membranes in order to access the mitochondrial DNA.
  • Together, these data support the development of PBGENE-PMM as a single-treatment, in vivo gene editing therapeutic for m.3243-associated primary mitochondrial myopathy.

Immunis Publishes Research Showing Secretomes Improve Metabolism and Muscle While Reducing Fat in Aged Models

Retrieved on: 
Tuesday, March 19, 2024
Men, Other Health, General Health, Pharmaceutical, Consumer, Infectious Diseases, Fitness & Nutrition, Biotechnology, Women, Alternative Medicine, Seniors, Vitamins, Supplements, Health, Metabolism, Adipose tissue, Obesity, Facial muscles, Connective tissue, Blood, Immunotherapy, Inc., Weight gain, Ageing, Fracture, Research, Mouse, DSM-IV codes, Aging Cell, University, Hope, Human, Muscle atrophy, Sarcopenic obesity, Therapy, Hospital, Dietary supplement

The study, published in Aging Cell, is entitled “ Stem cell secretome-treatment improves whole-body metabolism, reduces adiposity and promotes skeletal muscle function in aged mice .” The research examines the effects of Immunis’ investigational secretome on metabolism, fat and skeletal muscle in aged mouse models.

Key Points: 
  • The study, published in Aging Cell, is entitled “ Stem cell secretome-treatment improves whole-body metabolism, reduces adiposity and promotes skeletal muscle function in aged mice .” The research examines the effects of Immunis’ investigational secretome on metabolism, fat and skeletal muscle in aged mouse models.
  • As we age, our metabolic health declines and commonly manifests as obesity, muscle atrophy, and reduced physical function.
  • Dr. Drummond’s independent research in aged mouse models shows that Immunis’ immunotherapy, IMMUNA, increases whole-body lean mass and reduces fat mass, while increasing muscle fiber area.
  • Muscle quality improved such that there was an increase in muscle ‘stem’ cells, enhanced collagen turnover, more blood vessels and decreased muscle fat.

PURE Bioscience Reports Fiscal Second Quarter 2024 Financial Results

Retrieved on: 
Monday, March 18, 2024
Technology, Other Retail, Fitness & Nutrition, Biotechnology, Other Health, Food, Beverage, Health, Retail, Food Tech, Environment, International Association, IAFP, IPPE, Social media, Support, Marketing, PURE, SDC, Chemistry, Acceleration, Microbiology, Chemical industry, Advertising, OTCQB, Food safety, Food industry, Cryptocurrency

PURE Bioscience, Inc. ( OTCQB: PURE ) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for the fiscal second quarter ended January 31, 2024.

Key Points: 
  • PURE Bioscience, Inc. ( OTCQB: PURE ) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for the fiscal second quarter ended January 31, 2024.
  • Net product sales were $325,000 and $396,000 for the fiscal second quarter ended January 31, 2024 and 2023, respectively.
  • Net loss for the fiscal second quarter ended January 31, 2024 was $1,002,000, compared to $1,060,000 for the fiscal second quarter ended January 31, 2023.
  • Net loss, excluding share-based compensation, for the fiscal second quarter ended January 31, 2024 was $938,000, compared to $993,000 for the fiscal second quarter ended January 31, 2023.

US Foods Spring Scoop Introduces Great Tasting Menu Solutions Aimed at Trending Dietary and Lifestyle Preferences

Retrieved on: 
Monday, March 18, 2024
Men, Family, Restaurant, Bar, Fitness & Nutrition, Millennials, Consumer, Lifestyle, Publishing, Packaging, Food, Beverage, Generation Z, Generation X, Communications, Manufacturing, Retail, Other Consumer, Women, Sprouts, Flour, Garlic, Taste, Head, FD, Fungus, US Foods, FD&C, MSG, Plant, Cheese, Honey, Multimedia, Metro

US Foods Holding Corp. (NYSE: USFD) – one of America’s leading food service distributors – announced today the launch of its Spring 2024 Scoop™.

Key Points: 
  • US Foods Holding Corp. (NYSE: USFD) – one of America’s leading food service distributors – announced today the launch of its Spring 2024 Scoop™.
  • “With Spring Scoop, we’ve delivered a variety of on-trend, high-quality products that can meet specific preferences, while also appealing to all diners regardless of their dietary or lifestyle choices.
  • Most importantly, all products help save operators back-of-house labor and are highly versatile without sacrificing flavor.”
    US Foods “Serve You” products appeal to diners who want more personalization given their dietary and lifestyle preferences are great tasting and can work across a variety of menu options.
  • To view all the new products featured in Spring Scoop, visit the company’s Scoop webpage at usfoods.com/springscoop .

Immunis Chairman Dr. Hans Keirstead to Present Abundance360 Moonshot

Retrieved on: 
Monday, March 18, 2024
Surgery, Other Health, Other Science, Pharmaceutical, Oncology, Medical Devices, Infectious Diseases, Hospitals, Technology, Fitness & Nutrition, Clinical Trials, Stem Cells, Women, Science, Biotechnology, Practice Management, Seniors, Physical Therapy, Nanotechnology, Alternative Medicine, Managed Care, Medical Supplies, Men, FDA, Health, Diabetes, Consumer, Notifiable disease, Longevity, Facial muscles, Education, Patient, Ageing, Research, Sarcopenia, DSM-IV codes, Aging Cell, Quality of life, Human, Regenerative medicine, Safety, Fix, Muscle atrophy, Dietary supplement

Immunis, Inc., a private biotech company developing an innovative secretome for age-related diseases and immune dysfunction, announces that its Chairman, Dr. Hans Keirstead, will present at the annual Abundance360 in Los Angeles.

Key Points: 
  • Immunis, Inc., a private biotech company developing an innovative secretome for age-related diseases and immune dysfunction, announces that its Chairman, Dr. Hans Keirstead, will present at the annual Abundance360 in Los Angeles.
  • In fact, Abundance360 showcases “Moonshots,” or transformative ideas, from leaders who are making excellent strides to revolutionize human healthspan.
  • Dr. Keirstead’s Moonshot aims for the incredible goal of one day treating 500M individuals with Immunis’ investigational secretome (IMMUNA) to combat age-related immune dysfunction, targeting muscle atrophy and metabolic decline.
  • Dr. Keirstead’s Moonshot with IMMUNA aligns perfectly with his “Massive Transformative Purpose” to democratize regenerative medicine and enable everyone to live healthier lives.

Better Foods of Shinsegae Food Participates in NPEW to Accelerate Entry to U.S. Plant-based Food Market

Retrieved on: 
Monday, March 18, 2024
Food, Beverage, Health, Retail, Fitness & Nutrition, Organic Food, Meat, Multimedia, KRX, Exhibition, Marketing, Nuggets, Anaheim Convention Center, Fast food

Better Foods , Shinsegae Food’s (KRX: 031440) alternative food subsidiary, embarked on the U.S. market expansion by introducing ‘You are What you Eat,’ a plant-based food brand, at the Natural Product Expo West (NPEW) 2024.

Key Points: 
  • Better Foods , Shinsegae Food’s (KRX: 031440) alternative food subsidiary, embarked on the U.S. market expansion by introducing ‘You are What you Eat,’ a plant-based food brand, at the Natural Product Expo West (NPEW) 2024.
  • The NPEW, a leading exhibition introducing global natural food trends, stands as the world’s largest natural food show.
  • Following the latest participation, Better Foods has reflected the global plant-based food trend and sped up the U.S. market entry by adopting strategies customized to the local market.
  • “By participating in the NPEW 2024, we could verify the global market potential of plant-based food products using healthy ingredients,” a Better Foods official said.

Anthem Blue Cross and Blue Shield Foundation Awards $11 Million to Community Partners in New York

Retrieved on: 
Friday, March 15, 2024
Women, Other Philanthropy, Seniors, Men, General Health, Consumer, Food, Beverage, People with Disabilities, Retail, Mental Health, Parenting, Baby, Maternity, Health Insurance, Fitness & Nutrition, LGBTQ+, Philanthropy, Alternative Medicine, Health, Fund Raising, Foundation, Vitamins, Supplements, Well, BIPOC, American Heart Association, Culture, Conditional sentence, Organization, Food bank, Risk, Diabetes, Suds, City, Mental health, FAM, Elevance Health, Pregnancy, Woman, Partnership to End Addiction, New Yorker, 2005 in television, Blue Shield, Maternal health, Addiction, Hypertension, MHA, Clifford Whittingham Beers, Pharmaceutical industry

Anthem Blue Cross and Blue Shield Foundation continued its critical work to measurably improve health and strengthen local communities in 2023.

Key Points: 
  • Anthem Blue Cross and Blue Shield Foundation continued its critical work to measurably improve health and strengthen local communities in 2023.
  • “Our Foundation strives to improve the health of humanity by addressing health inequities and strengthening our communities in New York.
  • Our strategy underscores this commitment by focusing on partnerships and programs that aid the health of the socially vulnerable,” said Victor DeStefano, President of Anthem Blue Cross and Blue Shield in New York.
  • Other Anthem Blue Cross and Blue Shield Foundation grant recipients last year included: American Heart Association, Project Renewal, Gay Men’s Health Crisis, Community Access, and Tent Ministries.

HD Nursing and WellnessMats Announce Strategic Partnership, Improving Comfort and Safety of Healthcare Professionals with Medical Grade Premium Standing Solutions

Retrieved on: 
Friday, March 15, 2024
Other Professional Services, Health, Consumer, Other Health, Professional Services, Practice Management, Physical Therapy, Managed Care, General Health, Hospitals, Fitness & Nutrition, Seniors, Nursing, Medical Supplies, RN, Organization, Longevity, Partnership, Doctor of Philosophy, Safety, Patient safety, P4, HD, FAAN, Fatigue

“As the leader in Premium Standing Solutions and recognized for exemplary performance throughout various industries, we are thrilled to now join forces with HD Nursing and P4 to leverage our extensive experience to enhance the occupational comfort of medical and healthcare professionals,” says Daniel Bouzide, founder and president, WellnessMats. “This is a timely opportunity for healthcare leaders in virtually every healthcare setting to rethink and prioritize the well-being of their workforces and advance initiatives for employee retention -- one step at a time.”

Key Points: 
  • HD Nursing , the leading patient safety solution that combines predictive analytics with individualized fall and pressure injury prevention and WellnessMats , the leader in Premium Standing Solutions, proudly announce a strategic partnership.
  • This collaboration inaugurates a new era of improved comfort, safety, fatigue and stress relief for healthcare professionals and personnel throughout hospital and health system enterprises.
  • “This initiative underscores our joint dedication to advancing patient safety and supporting healthcare professionals throughout the healthcare ecosystem,” says Dr. Amy Hester, PhD, RN, BC, FAAN, chairwoman and CEO, HD Nursing.
  • Their professional-grade construction ensures a lasting investment that contributes to a positive work environment, improving employee retention and overall well-being.

Nature Made® Announces Great Race Title Sponsorship

Retrieved on: 
Thursday, March 14, 2024
Vitamins, Supplements, Sports, Other Retail, Fitness & Nutrition, Running, Lifestyle, Health, Consumer, Retail, Triple, Pharmavite, Science, The Great Race, Great race, Nature, Old, Wellness, Deena

Nature Made, the leading national vitamin and supplement broadline brand with over 50 years of delivering high-quality products backed by science has joined the Great Race as the title sponsor.

Key Points: 
  • Nature Made, the leading national vitamin and supplement broadline brand with over 50 years of delivering high-quality products backed by science has joined the Great Race as the title sponsor.
  • Now named The Nature Made® Great Race, this year’s event will take place on April 13 with more information available at https://www.greatrace.run/ .
  • “The Nature Made team is proud to be back at the Great Race this year as the title sponsor,” said Ali Kamen, Manager of Wellness & Engagement at Pharmavite.
  • “The Great Race has become a part of the fabric of our community, and we are deeply grateful to Nature Made for supporting us as title sponsor this year,” said Traci Greenberg, Race Director at the Great Race.

Institutional Property Advisors Brokers Sale and Arranges Financing for $94.5 Million Southeast Phoenix Multifamily Asset

Retrieved on: 
Thursday, March 14, 2024
Professional Services, Luxury, Family, Consumer, Convenience Store, Residential Building & Real Estate, Commercial Building & Real Estate, Construction & Property, Fitness & Nutrition, Retail, Finance, Health, Consulting, Bank of America, Intel, Walking, IPA, Bank, Microchip Technology, Sale, Acquisition, MMI, Marcus & Millichap, Grumman, The Park, Wells Fargo

Institutional Property Advisors (IPA), a division of Marcus & Millichap (NYSE: MMI), announced today the sale and financing of Alta Chandler at The Park, a 291-unit mid-rise multifamily asset in Chandler, Arizona.

Key Points: 
  • Institutional Property Advisors (IPA), a division of Marcus & Millichap (NYSE: MMI), announced today the sale and financing of Alta Chandler at The Park, a 291-unit mid-rise multifamily asset in Chandler, Arizona.
  • IPA Capital Markets arranged $52 million in acquisition financing.
  • Downtown Chandler is one mile from the property and within five miles there is 18.9 million square feet of retail and dining.
  • The property has an open-concept leasing office and clubhouse, a convenience market, sky lounge, fitness center, and a private, multi-purpose fitness room.